Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy-Reference-Cited by-同舟云学术

Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy

Published:2006-02 Issue:1 Volume:32 Page:48-55
ISSN:1677-5538
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Antunes Alberto A.¹,Crippa Alexandre¹,Dall'Oglio Marcos F.¹,Nesrallah Luciano J.¹,Leite Katia R.¹,Srougi Miguel¹

Affiliation:

1. University of Sao Paulo, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/pdf/ibju/v32n1/v32n1a08.pdf

Reference18 articles.

1. American Joint Committee on Cancer Manual for Staging Cancer;Beahrs OH,1992

2. Urologic Pathology;Gleason DF,1977

3. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer;Partin AW;A multi-institutional update,1997

4. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003;Khan MA;Urology,2003

5. Age as a prognostic factor for disease recurrence after radical prostatectomy;Obek C;Urology,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoexpression of HSPA9 and CUL2 in prostatic tissue and adenocarcinoma;Annals of Diagnostic Pathology;2022-02

2. Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis;Cancer Medicine;2020-07-22

3. Prognostic Factors for Overall Survival of Patients with Prostate Cancer in Kyadondo County, Uganda;Prostate Cancer;2020-01-27

4. Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria;Clinical Interventions in Aging;2016-07

5. Sobrevida e fatores prognósticos de pacientes com câncer de próstata clinicamente localizado;Revista de Saúde Pública;2010-04